Patent details

EP2617416 Title: CANCER HEAT THERAPY-ENHANCING AGENT

Basic Information

Publication number:
EP2617416
PCT Application Number:
PCT/JP/2011/005119
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP118247634
PCT Publication Number:
WO/2012/035747
First applicant's nationality:
Translation Language:
EPO Publication Language:
Not available
English Title of Invention:
CANCER HEAT THERAPY-ENHANCING AGENT
French Title of Invention:
AGENT POTENTIALISATEUR POUR THERMOTHÉRAPIE DU CANCER
German Title of Invention:
MITTEL ZUR VERSTÄRKUNG EINER KREBSWÄRMETHERAPIE
SPC Number:

Dates

Filing date:
12/09/2011
Grant date:
06/05/2015
EP Publication Date:
06/05/2015
PCT Publication Date:
22/03/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/07/2013
EP B1 Publication Date:
06/05/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
12/09/2015
Expiration date:
12/09/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/09/2011
 
 

Name:
SBI Pharmaceuticals Co. Ltd.
Address:
6-1, Roppongi 1-chome Minato-ku, Tokyo 106-6020, Japan (JP)

Name:
Tokyo University of Agriculture Educational
Address:
1-1, Sakuragaoka 1-chome, Setagaya-ku, Tokyo 156-8502, Japan (JP)

Inventor

1

Name:
NAKAJIMA Motowo
Address:
Japan (JP)

2

Name:
TANAKA Tohru
Address:
Japan (JP)

3

Name:
ABE Fuminori
Address:
Japan (JP)

4

Name:
TAKAHASHI Kiwamu
Address:
Japan (JP)

5

Name:
CHIBAZAKURA Taku
Address:
Japan (JP)

Priority

Priority Number:
2010206025
Priority Date:
14/09/2010
Priority Country:
Japan (JP)

Classification

Main IPC Class:
A61K 31/197;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages